Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
AMD, Nike, Zillow among UBS stock picks with the 'highest conviction' for 2023
04:22pm, Wednesday, 14'th Dec 2022 MarketWatch
'Tis the season for 2023 stock picks, and UBS analysts are out with their favorites, including AMD, Target, and Nike
Is Prometheus Biosciences a Good Stock to Buy Right Now?
10:32am, Friday, 09'th Dec 2022 The Motley Fool
This biotech stock just jumped over 180% in a single day, and investors want to know if there could be more big gains ahead.
Emergent (EBS) OTC Narcan Filing Gets FDA Priority Review Tag
04:08pm, Wednesday, 07'th Dec 2022 Zacks Investment Research
The FDA grants priority review to Emergent's regulatory filing seeking approval for an OTC version of its Narcan nasal spray. A final decision is expected by March 2023-end.
3 Unparalleled Stocks to Buy That Have Never Been This Cheap
10:21am, Monday, 05'th Dec 2022 The Motley Fool
These three leading companies are ripe for the picking and may never be this cheap again.
3 Unparalleled Stocks to Buy That Have Never Been This Cheap
05:21am, Monday, 05'th Dec 2022
These three leading companies are ripe for the picking and may never be this cheap again.
4 Analysts Have This to Say About Teva Pharmaceutical Indus
07:00pm, Wednesday, 23'rd Nov 2022 Benzinga
Teva Pharmaceutical Indus (NYSE:TEVA) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
0
1
2
0
Analyst Ratings for Teva Pharmaceutical Indus
06:01pm, Wednesday, 23'rd Nov 2022 Benzinga
Analysts have provided the following ratings for Teva Pharmaceutical Indus (NYSE:TEVA) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
0
Burlington Stores To Surge Over 21%? Plus Wedbush Slashes PT On Jack In The Box
01:58pm, Wednesday, 23'rd Nov 2022 Benzinga
Barclays raised the price target on Burlington Stores, Inc. (NYSE: BURL) from $164 to $230. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Burlington shares fell 0.1% to
What 4 Analyst Ratings Have To Say About Teva Pharmaceutical Indus
12:05pm, Wednesday, 23'rd Nov 2022 Benzinga
Teva Pharmaceutical Indus (NYSE:TEVA) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
1
0
1
2
0
Teva Pharmaceutical (TEVA) Names Richard Francis as New CEO
03:05pm, Tuesday, 22'nd Nov 2022 Zacks Investment Research
Teva Pharmaceutical (TEVA) appoints Richard Francis as the company's new president and chief executive officer, effective from Jan 1, 2023.
C-Suite Shakeup Pressures Teva Pharmaceutical Stock
10:49am, Monday, 21'st Nov 2022
Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is down 2.1% at $8.54 at last check, after the company named former Novartis (NVS) and Biogen (BIIB) executive Richard Francis as its new chief executi
TEVA Stock Alert: What to Know About Teva Pharmaceuticals' New CEO
10:37am, Monday, 21'st Nov 2022
Teva Pharmaceuticals (NYSE: TEVA ) stock is sliding on Monday after the company announced Richard Francis as its newest president and CEO. Francis will take over as the president and CEO of Teva Pharm
Teva names former Sandoz chief Richard Francis as new CEO
07:16am, Monday, 21'st Nov 2022
Teva Pharmaceutical Industries Ltd. TEVA, +0.93% on Monday said its current CEO Kåre Schultz will retire on Dec. 31.
Teva Pharmaceutical: Warren Buffett Likely Made A Mistake Selling Shares
03:55pm, Friday, 18'th Nov 2022
Teva Pharmaceutical was able to achieve a nationwide settlement to the opioid crisis, proving the ability of the company's management to overcome difficulties. Teva Pharmaceutical's provision for lega
AMD To Rally Around 39%? Here Are 5 Other Price Target Changes For Monday
12:07pm, Monday, 14'th Nov 2022 Benzinga
Baird raised Advanced Micro Devices, Inc. (NASDAQ: AMD) price target from $65 to $100. . Baird analyst Tristan Gerra upgraded the stock from Neutral to Outperform. AMD shares rose 5.7% to close at
